文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛心脑血管急症

通过减少器械死腔降低潮气量对脑损伤合并ARDS患者呼吸力学、气体交换及脑血流动力学的影响

Tidal Volume Lowering by Instrumental Dead Space Reduction in Brain-Injured ARDS Patients: Effects on Respiratory Mechanics, Gas Exchange, and Cerebral Hemodynamics.
PubMed 文献 · Neurocrit Care · 2021-01-01
一句话结论对脑损伤合并轻中度ARDS患者,用加热湿化器替代热湿交换器可减少死腔,从而在维持PaCO2不变的前提下安全降低潮气量和驱动压,且不改变脑灌注压和颅内压。

研究纳入18例格拉斯哥昏迷评分入院时<9分的脑损伤(颅脑创伤或自发性脑出血)合并轻中度ARDS患者,在持续肌松下按顺序接受三种通气策略:热湿交换器且调节潮气量使PaCO2在30-35 mmHg(HME1)、加热湿化器且调节潮气量使PaCO2相同(HH)、恢复HME1设置(HME2)。加热湿化器使潮气量降低120 ml(95%CI 98-144),潮气量/预测体重降低1.8 ml/kg(95%CI 1.5-2.1),平台压和驱动压降低3.7 cmH2O(95%CI 2.9-4.3),PaCO2、肺泡复张和氧合无变化。加热湿化器期间驱动压≤14 cmH2O者16例(89%),HME1和HME2期间分别为7例(39%)和8例(44%)(p<0.001)。平均动脉压、脑灌注压、颅内压和大脑中动脉平均血流速度均无变化。

要点

  • 脑损伤合并轻中度ARDS患者,用加热湿化器替代热湿交换器可降低潮气量120 ml(95%CI 98-144),PaCO2维持不变。
  • 加热湿化器使潮气量/预测体重降低1.8 ml/kg(95%CI 1.5-2.1),平台压和驱动压降低3.7 cmH2O(95%CI 2.9-4.3)。
  • 加热湿化器期间驱动压≤14 cmH2O者16例(89%),HME1和HME2期间分别为7例(39%)和8例(44%)(p<0.001)。
  • 加热湿化器期间平均动脉压、脑灌注压、颅内压和大脑中动脉平均血流速度均无变化。
  • 死腔减少源于气道死腔降低84 ml(95%CI -79至-89)和总死腔降低86 ml(95%CI -73至-98)。

适用人群与场景

  • 脑损伤患者(颅脑创伤或自发性脑出血,入院时格拉斯哥昏迷评分<9分)合并轻度至中度ARDS,在持续肌松下接受机械通气。

诊断标准与关键阈值

  • 纳入时中位PaO2/FiO2为173(四分位距146-213),中位PEEP为8 cmH2O(四分位距5-9)。
  • 轻度和中度ARDS分别为7例(39%)和11例(61%)。

处置流程与药物剂量

  • 第一步:使用热湿交换器,调节潮气量使PaCO2维持在30-35 mmHg(HME1)。
  • 第二步:换用加热湿化器,调节潮气量使PaCO2达到相同目标(HH)。
  • 第三步:恢复HME1设置(HME2)。
  • 加热湿化器使潮气量降低120 ml(95%CI 98-144),潮气量/预测体重降低1.8 ml/kg(95%CI 1.5-2.1)。
  • 加热湿化器使平台压和驱动压降低3.7 cmH2O(95%CI 2.9-4.3)。

研究设计与关键结果

  • 研究类型为在18例脑损伤合并轻中度ARDS患者中按顺序实施三种通气策略的生理学研究,无平行对照组。
  • 加热湿化器使潮气量降低120 ml(95%CI 98-144),潮气量/预测体重降低1.8 ml/kg(95%CI 1.5-2.1),平台压和驱动压降低3.7 cmH2O(95%CI 2.9-4.3),PaCO2、肺泡复张和氧合无变化。
  • 加热湿化器期间驱动压≤14 cmH2O者16例(89%),HME1期间7例(39%),HME2期间8例(44%)(p<0.001)。
  • 加热湿化器期间平均动脉压、脑灌注压、颅内压和大脑中动脉平均血流速度均无变化。
  • 死腔减少:气道死腔降低84 ml(95%CI -79至-89),总死腔降低86 ml(95%CI -73至-98)。

证据类型、等级与局限

  • 证据类型为在18例患者中按顺序实施三种通气策略的生理学研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对脑损伤合并轻中度ARDS患者,用加热湿化器替代热湿交换器可减少器械死腔,从而在PaCO2不变的情况下降低潮气量和驱动压,且不改变脑血流动力学。
  • 加热湿化器使更高比例的患者(89% vs HME1的39%和HME2的44%)达到驱动压≤14 cmH2O。
  • 作者认为,减少死腔可安全降低潮气量而不改变PaCO2和脑灌注,使更大部分的脑损伤ARDS患者接受损伤更小的通气。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Limiting tidal volume (VT), plateau pressure, and driving pressure is essential during the acute respiratory distress syndrome (ARDS), but may be challenging when brain injury coexists due to the risk of hypercapnia. Because lowering dead space enhances CO2 clearance, we conducted a study to determine whether and to what extent replacing heat and moisture exchangers (HME) with heated humidifiers (HH) facilitate safe VT lowering in brain-injured patients with ARDS.

METHODS: Brain-injured patients (head trauma or spontaneous cerebral hemorrhage with Glasgow Coma Scale at admission < 9) with mild and moderate ARDS received three ventilatory strategies in a sequential order during continuous paralysis: (1) HME with VT to obtain a PaCO2 within 30-35 mmHg (HME1); (2) HH with VT titrated to obtain the same PaCO2 (HH); and (3) HME1 settings resumed (HME2). Arterial blood gases, static and quasi-static respiratory mechanics, alveolar recruitment by multiple pressure-volume curves, intracranial pressure, cerebral perfusion pressure, mean arterial pressure, and mean flow velocity in the middle cerebral artery by transcranial Doppler were recorded. Dead space was measured and partitioned by volumetric capnography.

RESULTS: Eighteen brain-injured patients were studied: 7 (39%) had mild and 11 (61%) had moderate ARDS. At inclusion, median [interquartile range] PaO2/FiO2 was 173 [146-213] and median PEEP was 8 cmH2O [5-9]. HH allowed to reduce VT by 120 ml [95% CI: 98-144], VT/kg predicted body weight by 1.8 ml/kg [95% CI: 1.5-2.1], plateau pressure and driving pressure by 3.7 cmH2O [2.9-4.3], without affecting PaCO2, alveolar recruitment, and oxygenation. This was permitted by lower airway (- 84 ml [95% CI: - 79 to - 89]) and total dead space (- 86 ml [95% CI: - 73 to - 98]). Sixteen patients (89%) showed driving pressure equal or lower than 14 cmH2O while on HH, as compared to 7 (39%) and 8 (44%) during HME1 and HME2 (p < 0.001). No changes in mean arterial pressure, cerebral perfusion pressure, intracranial pressure, and middle cerebral artery mean flow velocity were documented during HH.

CONCLUSION: The dead space reduction provided by HH allows to safely reduce VT without modifying PaCO2 nor cerebral perfusion. This permits to provide a wider proportion of brain-injured ARDS patients with less injurious ventilation.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Pitoni S, D'Arrigo S, Grieco DL, et al. Tidal Volume Lowering by Instrumental Dead Space Reduction in Brain-Injured ARDS Patients: Effects on Respiratory Mechanics, Gas Exchange, and Cerebral Hemodynamics. Neurocrit Care. 2021. PMID: 32323146. doi:10.1007/s12028-020-00969-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。